Contract Services Methods Development
China Marks a Landmark Moment as BioDlink and Lepu Biopharma Launch the World’s First EGFR Targeting ADC
Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their par...
November 24, 2025 | News
Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA
Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...
November 18, 2025 | News
Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...
November 13, 2025 | News
Mölnlycke Establishes First Wound Care Manufacturing Site in China to Strengthen Local Production and Supply Chain Resilience
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound car...
November 06, 2025 | News
Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...
November 05, 2025 | News
Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics
Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...
November 04, 2025 | News
Lonza to Acquire Redberry SAS, Advancing Rapid Microbiology Testing with Solid-Phase Cytometry Technology
Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced that it has signed an agreement to acquire ...
October 31, 2025 | News
NEOM and WuXi AppTec Partner to Build World-Class Pharmaceutical R&D and Manufacturing Capabilities in Saudi Arabia
NEOM, the sustainable region taking shape in northwest Saudi Arabia, has signed a strategic memorandum of understanding (MoU) with WuXi AppTec, a leading g...
October 28, 2025 | News
Curia Invests $4 Million to Upgrade API Aseptic Suites in Spain to Meet New EU GMP Annex 1 Standards
Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investmen...
October 28, 2025 | News
Syngene Strengthens India’s ADC Ecosystem With New GMP Bioconjugation Suite in Bengaluru
Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...
October 24, 2025 | News
SunRock Biopharma and Chime Biologics Partner to Advance Novel Anti-CCR9 Antibody Therapy for Inflammatory Bowel Disease
SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contrac...
October 22, 2025 | News
AstraZeneca Invests $445 Million to Expand Texas Manufacturing Hub in the United States, Doubling Global Lokelma Production
AstraZeneca announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the...
October 16, 2025 | News
LTS Acquires Renaissance Lakewood to Expand Global CDMO Capabilities in Nasal and Sterile Drug Delivery
LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company announces the acquisition of Renaissance Lakewood, LLC ("Renaissance")...
October 14, 2025 | News
Renalys Pharma Completes Primary Endpoint Data Collection in Phase III Sparsentan Trial for IgA Nephropathy
Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") announced that it has completed data collection for the primary endpoint in the Phase I...
October 13, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
